Millennium Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-819,774
Closed -$97.1M 7492
2021
Q1
$97.1M Buy
819,774
+229,264
+39% +$27.1M 0.07% 243
2020
Q4
$69.7M Buy
590,510
+326,636
+124% +$37.9M 0.05% 317
2020
Q3
$29.3K Buy
263,874
+128,402
+95% +$13.8M 0.04% 570
2020
Q2
$13.8M Sell
135,472
-12,094
-8% -$1.29M 0.02% 981
2020
Q1
$15.9M Buy
147,566
+127,382
+631% +$14.6M 0.04% 559
2019
Q4
$2.35M Buy
20,184
+13,484
+201% +$1.56M ﹤0.01% 2512
2019
Q3
$766K Sell
6,700
-8,853
-57% -$880K ﹤0.01% 3007
2019
Q2
$1.48M Buy
15,553
+6,845
+79% +$645K ﹤0.01% 2586
2019
Q1
$795K Buy
+8,708
New +$713K ﹤0.01% 3004
2018
Q1
Sell
-33,176
Closed -$2.61M 4383
2017
Q4
$2.61M Buy
33,176
+9,932
+43% +$826K ﹤0.01% 2116
2017
Q3
$2.15M Buy
23,244
+18,910
+436% +$1.82M ﹤0.01% 2128
2017
Q2
$490K Sell
4,334
-40,039
-90% -$4.47M ﹤0.01% 2812
2017
Q1
$4.44M Sell
44,373
-16,112
-27% -$1.72M 0.01% 1530
2016
Q4
$6.5M Buy
60,485
+168
+0.3% +$19.6K 0.01% 1160
2016
Q3
$7.51M Buy
60,317
+31,991
+113% +$3.78M 0.01% 1089
2016
Q2
$3.01M Buy
+28,326
New +$3.29M 0.01% 1561
2015
Q4
Sell
-84,213
Closed -$7.56M 3996
2015
Q3
$7.56M Buy
84,213
+37,416
+80% +$3.95M 0.01% 1095
2015
Q2
$5.39M Buy
+46,797
New +$4.92M 0.01% 1352
2015
Q1
Sell
-39,658
Closed -$2.67M 4399
2014
Q4
$2.67M Buy
39,658
+29,727
+299% +$1.84M 0.01% 1784
2014
Q3
$536K Buy
+9,931
New +$489K ﹤0.01% 2703

Millennium Management's CBPO Position: Q2 2021 in Review

Millennium Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 819,774 shares — an estimated $97.1M sold.

Millennium Management first reported a position in CBPO in Q3 2014 and held it in 20 quarters. The position peaked at $97.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Millennium Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Millennium Management sold 819,774 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $97.1M.
  • Millennium Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2014 and held it in 20 quarters.
  • Millennium Management's China Biologic Products Holdings, Inc. position peaked at $97.1M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.